Chargement en cours...
Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study
BACKGROUND AND AIMS—The benefit of 5-aminosalicylic acid therapy for maintenance of remission in Crohn's disease is controversial. The primary aim of this study was to evaluate the prophylactic properties of olsalazine in comparison with placebo for maintenance of remission in quiescent Crohn&#...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2001
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1728458/ https://ncbi.nlm.nih.gov/pubmed/11559654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.49.4.552 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|